The estimated Net Worth of Michael D Wortley is at least $23.1 Milion dollars as of 15 August 2023. Mr. Wortley owns over 1,205 units of Reata Pharmaceuticals Inc stock worth over $8,566,464 and over the last 9 years he sold RETA stock worth over $12,461,207. In addition, he makes $2,033,950 as Executive Vice President i Chief Legal Officer at Reata Pharmaceuticals Inc.
Michael has made over 6 trades of the Reata Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,205 units of RETA stock worth $203,585 on 15 August 2023.
The largest trade he's ever made was selling 51,429 units of Reata Pharmaceuticals Inc stock on 11 November 2020 worth over $9,224,820. On average, Michael trades about 3,339 units every 65 days since 2015. As of 15 August 2023 he still owns at least 49,701 units of Reata Pharmaceuticals Inc stock.
You can see the complete history of Mr. Wortley stock trades at the bottom of the page.
Michael D. Wortley serves as Executive Vice President, Chief Legal Officer of the Company. Prior to joining Reata, Prior to joining Reata, Mr. Wortley was an attorney at Vinson & Elkins LLP from 1995 to March 2015, serving in various capacities, including Chief Operating Partner of the firm and Managing Partner of the Dallas office, and, prior to 1995, at Johnson & Wortley, P.C., serving as Chairman of the Board and President. He currently serves on the board of directors of Pioneer Natural Resources Company. Mr. Wortley earned a B.A. in Political Science from Southern Methodist University, a Master’s degree in Regional Planning from the University of North Carolina at Chapel Hill and a J.D. from Southern Methodist University Dedman School of Law.
As the Executive Vice President i Chief Legal Officer of Reata Pharmaceuticals Inc, the total compensation of Michael Wortley at Reata Pharmaceuticals Inc is $2,033,950. There are 3 executives at Reata Pharmaceuticals Inc getting paid more, with Manmeet Soni having the highest compensation of $12,612,200.
Michael Wortley is 72, he's been the Executive Vice President i Chief Legal Officer of Reata Pharmaceuticals Inc since 2018. There are 1 older and 14 younger executives at Reata Pharmaceuticals Inc. The oldest executive at Reata Pharmaceuticals Inc is Michael D. Wortley, 73, who is the Exec. VP & Chief Legal Officer.
Michael's mailing address filed with the SEC is 5320 LEGACY DRIVE, , PLANO, TX, 75024.
Over the last 9 years, insiders at Reata Pharmaceuticals Inc have traded over $176,850,875 worth of Reata Pharmaceuticals Inc stock and bought 8,443,489 units worth $179,313,590 . The most active insiders traders include Holdings A/S Novo, R Kent Jr Mc Gaughy oraz Inc Cpmg. On average, Reata Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $10,950,893. The most recent stock trade was executed by Andrea Loewen on 14 September 2023, trading 3,175 units of RETA stock currently worth $546,195.
reata pharmaceuticals, inc. (nasdaq:reta) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Inc executives and other stock owners filed with the SEC include: